Genprex, Inc. (GNPX) Balance Sheet

NASDAQ: GNPXAssets, liabilities, debt and equity over 10 years.

GNPX balance sheet, 2025

December 31, 2025 · U.S. dollars

$10.2M assets = $2.2M liabilities + $8.0M equity

What it owns$10.2MCash & ST investments: $7.8M (77.1%)Cash & ST investments$7.8M · 77%Other current: $525,928 (5.2%)Other non-current: $1.8M (17.7%)Other non-current$1.8M · 18%=How it is financed$10.2MCurrent liabilities: $2.2M (21.4%)Current liabilities$2.2M · 21%Other LT liabilities: $22,500 (0.2%)Shareholders’ equity: $8.0M (78.4%)Shareholders’ equity$8.0M · 78%

Both columns are drawn to the same scale: what GNPX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GNPX financial health

Current ratio3.84
Comfortable · current assets cover current liabilities 3.84×
Equity / assets78.4%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GNPX balance sheet trends, 2016–2025

Genprex, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$1.9M2016$10.2M2025+20.4%/yr
Total liabilities$285,6612016$2.2M2025+25.4%/yr
Shareholders’ equity$1.6M2016$8.0M2025+19.3%/yr
Cash & short-term investments$1.6M2016$7.8M2025+19.3%/yr
Total debt$201,8902017$92,7502019−32.2%/yr
Net cash (debt)−$40,6392017$1.9M2019+$2.0M
Working capital$1.4M2016$6.2M2025+$4.8M
Current ratio5.7420163.842025−1.89
Debt / equity0.4720170.032019−0.44

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GNPX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GNPX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GNPX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GNPX balance sheet

Genprex, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$7.8M$1.6M$6.7M$21.0M$38.6M$27.3M$2.0M$8.6M$161,251$1.6M
Cash & equivalents$7.8M$1.6M$6.7M$21.0M$38.6M$27.3M$2.0M$8.6M$161,251$1.6M
Short-term investments—$1.60B——————$0—
Receivables$0$0$0$34,852$0$127$655$9,297$8,844$8,181
Inventory$0$0$0$0$0$3.0M$801,780$0$0$0
Other current assets$525,928$475,807$794,138$484,224$511,348$384,553$171,716$236,851$23,479$28,352
Total current assets$8.4M$2.1M$7.5M$21.5M$39.1M$30.7M$3.0M$8.8M$193,574$1.6M
Property, plant & equipment (net)$0$0$7,859$23,032$48,608$39,441$44,654$24,354$7,804$5,157
Goodwill & intangible assets$0$0$773,478$702,095$642,360$601,625$491,200$379,451$298,569$241,037
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$1.8M$2.0M$2.4M$2.9M$3.0M$10,741$21,732$18,085$759,591$25,507
Total assets$10.2M$4.1M$10.7M$25.1M$42.9M$31.4M$3.5M$9.3M$1.3M$1.9M
Liabilities
Accounts payable$743,070$1.1M$1.4M$442,925$973,195$192,968$436,258$295,069$629,074$109,661
Short-term debt——————$74,430$92,750$201,890—
Total current liabilities$2.2M$2.5M$3.3M$2.8M$1.6M$450,724$510,684$387,821$830,964$285,661
Long-term debt$0$0$0$0$0$0$0$0$0$0
Other long-term liabilities$22,500$0$0$442,925$0$0$0$0$0$0
Total liabilities$2.2M$2.5M$3.3M$2.8M$1.6M$450,724$510,684$387,821$830,964$285,661
Shareholders' equity
Common stock & paid-in capital$3,291$10,861$1,486$1,203$47,874$43,118$19,264$15,240$11,721$328
Retained earnings (deficit)−$171.0M−$154.8M−$133.7M−$102.8M−$79.1M−$58.4M−$40.5M−$29.8M−$17.5M−$14.1M
Treasury stock————————$0—
Accumulated other comprehensive income——$0$0————$0—
Minority interest————————$0—
Total shareholders' equity$8.0M$1.6M$7.4M$22.3M$41.3M$30.9M$3.0M$8.9M$428,574$1.6M
Key figures
Total debt——————$92,750$92,750$201,890—
Net cash (debt)——————$1.9M$8.5M−$40,639—
Working capital$6.2M−$426,703$4.3M$18.7M$37.6M$30.3M$2.5M$8.5M−$637,390$1.4M
Tangible book value$8.0M$1.6M$6.6M$21.6M$40.6M$30.3M$2.5M$8.5M$130,005$1.4M
Current ratio3.840.832.317.6424.6968.155.8322.810.235.74
Quick ratio3.600.642.077.4724.3760.613.9222.200.205.64
Debt / equity——————0.030.010.47—
Equity / assets78.4%39.3%69.5%88.8%96.3%98.6%85.6%95.8%34.0%85.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.

GNPX financial position

At the end of fiscal 2025 (December 31, 2025), Genprex had total assets of $10.2 million (up 146.3% from a year earlier), total liabilities of $2.2 million and shareholders' equity of $8.0 million. Its current ratio was 3.84. In the latest quarter (ended June 30, 2026) total assets were $17.1 million and equity $14.8 million.

Related: GNPX income statement, GNPX cash flow statement, GNPX key metrics. See the GNPX stock overview for the latest quote and news.

GNPX balance sheet FAQ

What are Genprex's total assets?

Genprex reported total assets of $10.2 million at the end of fiscal 2025 (December 31, 2025), compared with $4.1 million a year earlier.

How much cash does Genprex have?

Genprex held $7.8 million in cash and short-term investments at the end of fiscal 2025.

What is Genprex's book value?

Genprex's shareholders' equity (book value) was $8.0 million at the end of fiscal 2025.

What is Genprex's current ratio?

Genprex had current assets of $8.4 million and current liabilities of $2.2 million, a current ratio of 3.84 (it can cover its short-term obligations).

Biotechnology: balance sheet